APPLICATIONS PUBLISHED 28 JULY 2004

Published: 1-Feb-2005

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Stratified cartilage tissue and methods to engineer same
    Rush-Presbyterian-St Luke's Medical Centre; University of California, San Diego 1435980*

  • Anti-tumour activity from reptile serum
    Natural Cure 1435981*

  • Delivery system for pharmaceutical, nutrition and cosmetic ingredients
    Natreon; Indian Herbs Research & Supply 1435982*

  • Concentrate comprising green tea, grape skin extract and grape seed extract, the production thereof and the use of the same
    Rudolf Wild 1435933*

  • Use of histamine to treat liver disease
    Maxim Pharmaceuticals 1435934*

  • Medicament containing activated antithrombin III
    Kehrel, Beate 1435985*

  • IGF-binding protein-derived peptide or small molecule
    Bioexpertise 1435986*

  • Method and compsn for treating immune complex associated disorders
    The Trustees of Boston University 1435987*

  • Improved use of antitumoral compound in cancer therapy
    Pharmamar 1435988*

  • TP1B inhibitors and ligands
    Albert Einstein College of Medicine of Yeshiva University 1435989*

  • Kahalide compounds for use in cancer therapy
    Pharma Mar 1435990*

  • Use of alpidine for the treatment of pancreatic cancer
    Pharma Mar 1435991*

  • Chemokines as adjuvants of immune responses
    Schering 1435992*

  • Novel use for pulmonary surfactant
    Altana Pharma 1435994*

  • Compsn and method for treating diabetes
    GMP Endotherapeutics 1435995*

  • Compsn comprising mixtures of therapeutic proteins and methods of producing the same
    Genetrol Biotherapeutics 1435996*

  • Method for treating hepatitis C virus infection in treatment failure patients
    Intermune 1435997*

  • Method for treating hepatitis C virus infection in treatment failure patients
    Intermune 1435998*

  • Additive cytoprotective effects of two bioactive regions of pro-optiomelanocortin hormone
    Ademovic, Zlatko; Konjevoda, Pasko; Mikus, Darko 1435999*

  • Treatment of non-solid mammalian tumours with vascular endothelial growth factor receptor antagonists
    Imclone Systems 1436000*

  • Inhibition of neonatal hyperbilirubinemia in breast fed infants
    Wisconsin Alumni Research Foundation 1436005*

  • Viral inhibition by N-docosanol
    Avanir Pharmaceuticals 1436006*

  • Compounds for use as surfactants
    Glaxo Group 1436007*

  • Controlled release drug delivery compsn comprising polycationic polymer and negatively charged pharmacologically active compound
    The University of British Columbia; Arc Pharmaceuticals 1436008*

  • Pharmaceutical formulation
    AstraZeneca 1436009*

  • Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compsns and methods
    3M Innovative Properties 1436010*

  • Dandrimers for use in targeted delivery
    University of Strathclyde; The University Court of the University of Glasgow 1436011*

  • Polymer conjugates of opioid antagonists
    Nektar Therapeutics 1436012*

  • You may also like